Lipid disorders in blue-collar workers in Lubelskie region
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.041Keywords
Dyslipidemias, Cardiovascular DiseasesAbstract
Introduction
Lipid disorders are the most important risk factor of cardiovascular disease (CVD). For clinical practice and assessment of patient`s cardiovascular risk the most relevant is to determine plasma concentration of low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C). Blue-collar workers are a group of patients with higher estimated cardiovascular risk than other workers groups.
The aim of the study
The aim of the study was to asses prevalence of lipid disorders in blue-collar workers from Lubelskie region.
Material and methods
The method of this paper was to perform a retrospective analysis of data provided by the National Health Fund. The study population enclosed patients aged 35, 40, 45, 50, 55 included in the Cardiovascular Disease Prevention Program held in Primary Healthcare (PH) setting on the area of Lubelskie region in years 2008-2018. Patients analyzed were blue-collar workers. The chi-square test was used to test the relationship between the two qualitative features and the Pearson linear correlation between the quantitative features. The analyzes were performed using the IBM SPSS Statistics for Windows, version 25 program (IBM Corp., Armonk, N.Y., USA). The significance level was assumed to be α = 0,05.
Results
In 26 226 patients hyperlipidemia was observed in 65,6% and LDL cholesterol levels higher than 115 mg/dl in 52,8% of patients. The mean total cholesterol serum concentration was 203,8 mg/dl, LDL cholesterol - 120,1 mg/dl and median triglycerides concentration – 101,0 mg/dl.
Conclusions
Hyperlipidemia was a common problem in blue-collar workers in Lubelskie region in years 2008-2018. Intense prophylactic actions are needed to reduce cardiovascular risk of this group of population.
References
Tabas I, Williams KJ, Borén Jan. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832–44.
Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nature Genetics 2013;45:1345-52.
Colantonio LD, Bittner V, Reynolds K, Levitan EB, Rosenson RS, Banach M, et al. Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies. Circulation 2016;133:256–64.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk European Heart Journal 2020;41:1:111–88.
Aginsky KD, Constantinou D, Delport M, Watson ED. Cardiovascular Disease Risk Profile and Readiness to Change in Blue- and White-Collar Workers. Fam Community Health. 2017;40(3):236-244.
Kelsall HL, Fernando PHS, Gwini SM, Sim MR. Cardiovascular Disease and Type 2 Diabetes Risk Across Occupational Groups and Industry in a Statewide Study of an Australian Working Population. J Occup Environ Med. 2018;60(3):286-294.
Pająk A, Szafraniec K, Polak M, Polakowska M, Kozela M, Piotrowski W, et al.Changes in the prevalence, management and treatment of hypercholesterolemia and other dyslipidemias over 10 years in Poland. The WOBASZ study. Polish Archives of Internal Medicine 2016;126:9:642‐652.
Zdrojewski T, Bandosz P, Szpakowski P, Konarski R, Manikowski A, Wołkiewicz E,et al. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. [Prevalence of the main risk factors for cardiovascular diseases in Poland. The results of the NATPOL PLUS study.] Kardiologia Polska 2004;61:(Supl. 4):1-26.
Zdrojewski T, Solnica B, Cybulska B, Bandosz P, Rutkowski M, Stokwiszewski J, et al. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiologia Polska 2016:213–23.
Pająk A, Wiercińska E, Polakowska M, Kozakiewicz K, Kaczmarczyk-Chałas K, Tykarski A, et al. Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lat w Polsce. Wyniki programu WOBASZ. [Dyslipidemia prevalence in men and women aged 20–74 in Poland. WOBASZ results.] Kardiologia Polska 2005; 63:(Supl. 4):620-6.
Pająk A, Szafraniec K, Polak M, Polakowska M, Kozela M, Piotrowski W, et al.Changes in the prevalence, management and treatment of hypercholesterolemia and other dyslipidemias over 10 years in Poland. The WOBASZ study. Polish Archives of Internal Medicine 2016;126:9:642‐652.
Colantonio LD, Bittner V, Reynolds K, Levitan EB, Rosenson RS, Banach M, et al.Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies. Circulation 2016;133:256–64.
Rynkiewicz A, Cybulska B, Banach M, Filipiak K, Guzik T, Idzior-Waluś B, et al. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. Journal of Clinical Lipidology 2013;7:217–21.
Pajak A, Szafraniec K, Polak M, Drygas W, Piotrowski W, Zdrojewski T, et al.Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational,population-based studies in Poland. Archives of Medical Science 2016;4:687–96.
Jóźwiak J, Mastej M, Lukas W, Piwowarska W, Konduracka E, Tykarski A. Badanie LIPIDOGRAM2004 vs LIPIDOGRAM 2006. Czy sytuacja epidemiologiczna w zakresie zaburzeń lipidowych uległa zmianie? [Study LIPIDOGRAM2004 vs LIPIDOGRAM 2006. Has the epidemiological situation in the field of lipid disorders changed?] Problemy Medycyny Rodzinnej 2007;9:78-81.
Jóźwiak J, Mastej M, Lukas W. LIPIDOGRAM2003 – Ocena i porównanie parametrów pełnego lipidogramu i wskaźnika masy ciała BMI w zależności od płci i wieku w populacjipacjentów Polski południowej i zachodniej. Część II: częstość występowania zaburzeń lipidowych w zależności od płci i BMI. [LIPIDOGRAM2003 - Assessment and comparison of the parameters of the full lipidogram and BMI body mass index depending on gender and age in the population of patients in southern and western Poland. Part II: The incidence of lipid disorders by gender and BMI.] Problemy Medycyny Rodzinnej 2005;7:33-9.
Halcox JP, Banegas JR, Roy C, Dallongeville J, Backer GD, Guallar E, et al. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovascular Disorders 2017;17:1:160.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 526
Number of citations: 0